Results for &quot;&quot;WT1 Proteins&quot;&quot;[mesh_terms]

Immunotherapy for leukemia targeting the Wilms' tumor gene.

M Yasukawa

Leukemia & lymphoma 2002;42(3):267-73

Implications of the transcription factor WT1 linked to the pathologic cardiac remodeling post-myocardial infarction.

Raúl Lelio Sanz, Luciana Mazzei, Walter Manucha

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis 2020;31(3):121-127

Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.

Benjamin Uttenthal, Irma Martinez-Davila, Adam Ivey, Charles Craddock, Frederick Chen, Andras Virchis, Panagiotis Kottaridis, David Grimwade, Asim Khwaja, Hans Stauss, Emma C Morris

British journal of haematology 2014;164(3):366-75

Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy.

Shuichi Ota, Mamiko Miyashita, Yuka Yamagishi, Masahiro Ogasawara

Human vaccines & immunotherapeutics 2022;17(12):5563-5572

A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.

Rosemary W Heathcott, Ian M Morison, Marie Claire Gubler, Robin Corbett, Anthony E Reeve

Human mutation 2002;19(4):462

Fallopian tube malignant mixed müllerian tumor (carcinosarcoma): a case report with immunohistochemical profiling.

H P Kourea, G Adonakis, G Androutsopoulos, P Zyli, G Kourounis, G Decavalas

European journal of gynaecological oncology 2009;29(5):538-42

DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.

Tove Ullmark, Giorgia Montano, Urban Gullberg

European journal of haematology 2018;100(3):229-240

An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis.

Karla F S Melo, Regina M Martin, Elaine M F Costa, Filomena M Carvalho, Alexander A Jorge, Ivo J P Arnhold, Berenice B Mendonca

The Journal of clinical endocrinology and metabolism 2002;87(6):2500-5

T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization.

Katayoun Rezvani, Jason M Brenchley, David A Price, Yasemin Kilical, Emma Gostick, Andrew K Sewell, Jongming Li, Stephan Mielke, Daniel C Douek, A John Barrett

Clinical cancer research : an official journal of the American Association for Cancer Research 2006;11(24 Pt 1):8799-807

MicroRNA-191, regulated by HIF-2α, is involved in EMT and acquisition of a stem cell-like phenotype in arsenite-transformed human liver epithelial cells.

Chao Chen, Qianlei Yang, Dapeng Wang, Fei Luo, Xinlu Liu, Junchao Xue, Ping Yang, Hui Xu, Jiachun Lu, Aihua Zhang, Qizhan Liu

Toxicology in vitro : an international journal published in association with BIBRA 2018;48():128-136

Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms.

Yan Li, Jiying Wang, Xiaoyan Li, Yujiao Jia, Lei Huai, Kan He, Pei Yu, Min Wang, Haiyan Xing, Qing Rao, Zhen Tian, Kejing Tang, Jianxiang Wang, Yingchang Mi

Oncology reports 2015;32(6):2680-6

Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.

Elena Provasi, Pietro Genovese, Angelo Lombardo, Zulma Magnani, Pei-Qi Liu, Andreas Reik, Victoria Chu, David E Paschon, Lei Zhang, Jurgen Kuball, Barbara Camisa, Attilio Bondanza, Giulia Casorati, Maurilio Ponzoni, Fabio Ciceri, Claudio Bordignon, Philip D Greenberg, Michael C Holmes, Philip D Gregory, Luigi Naldini, Chiara Bonini

Nature medicine 2012;18(5):807-815

Prognostic Impact of PD-1 Polymorphisms in Non-small Cell Lung Cancer Receiving Dendritic Cell Vaccination.

Masahiro Ogasawara, Mamiko Miyashita, Yuka Yamagishi, Shuichi Ota

Anticancer research 2025;45(10):4295-4304

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.

Yoshihiro Oka, Akihiro Tsuboi, Tetsuya Taguchi, Tadashi Osaki, Taiichi Kyo, Hiroko Nakajima, Olga A Elisseeva, Yusuke Oji, Manabu Kawakami, Kazuhiro Ikegame, Naoki Hosen, Satoshi Yoshihara, Fei Wu, Fumihiro Fujiki, Masaki Murakami, Tomoki Masuda, Sumiyuki Nishida, Toshiaki Shirakata, Shin-Ichi Nakatsuka, Ayako Sasaki, Keiko Udaka, Hiroo Dohy, Katsuyuki Aozasa, Shinzaburo Noguchi, Ichiro Kawase, Haruo Sugiyama

Proceedings of the National Academy of Sciences of the United States of America 2004;101(38):13885-90